The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients with endometrial cancer: Expectations and preferences towards therapy and quality of life—First results of an international survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI).
 
Lukas Chinczewski
No Relationships to Disclose
 
Catherine Krause
Employment - Charité University Medicine Berlin
 
Dario Zocholl
No Relationships to Disclose
 
Jolijn Boer
No Relationships to Disclose
 
Tibor Zwimpfer
No Relationships to Disclose
 
Clemens Liebrich
No Relationships to Disclose
 
Petra Adámková
No Relationships to Disclose
 
David M. Atallah
No Relationships to Disclose
 
Sarah Sultan Al-Rubaish
No Relationships to Disclose
 
Dana Lucia Stanculeanu
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly O.; MSD; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly O.; MSD; Novartis; Pfizer; Roche; SERVIER
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly O.; MSD; Novartis; Pfizer; Roche; SERVIER
 
Dilyara Kaidarova
No Relationships to Disclose
 
Jonathan S. Berek
Leadership - Oncoquest
Research Funding - Aravive (Inst); Eisai (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst); Tesaro (Inst); Zentalis (Inst)
 
Judith Lafleur
No Relationships to Disclose
 
Maria-Pilar Barretina-Ginesta
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar; Roche
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar; Roche
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar; Roche
 
Pavel Havelka
No Relationships to Disclose
 
Klaus Pietzner
Honoraria - AstraZeneca; Eisai; Merck Sharp & Dohme; Novartis; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Novartis; Roche; Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro/GSK
 
Flurina Saner
No Relationships to Disclose
 
Susanne Fechner
No Relationships to Disclose
 
Viola A. Heinzelmann-Schwarz
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - Alkermes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro